Liver TransplantationImmunosuppressive AgentsGraft RejectionKidney TransplantationTacrolimusLiver FailureGraft SurvivalTransplantationLiver DiseasesTissue DonorsPostoperative ComplicationsLiving DonorsCyclosporineMycophenolic AcidCytomegalovirus InfectionsOrgan TransplantationEnd Stage Liver DiseaseTreatment OutcomeRetrospective StudiesLiver CirrhosisImmunosuppressionTissue and Organ ProcurementTime FactorsTransplantation, HomologousHeart TransplantationLiverLung TransplantationTransplantsHepatitis CTransplantation ImmunologyImmunocompromised HostLiver NeoplasmsWaiting ListsGanciclovirAntiviral AgentsRecurrenceRisk FactorsPostoperative PeriodCadaverLiver Function TestsCytomegalovirusOpportunistic InfectionsFollow-Up StudiesCalcineurinDrug Therapy, CombinationMycosesAspergillosisBiopsyIncidenceSirolimusProspective StudiesLymphoproliferative DisordersRisk AssessmentRoseolovirus InfectionsSurvival AnalysisHepatic ArteryMonitoring, ImmunologicBone Marrow TransplantationTransplantation ToleranceCreatinineSurvival RateAntifungal AgentsRenal InsufficiencyFatal OutcomeCholestasisCarcinoma, HepatocellularKaplan-Meier EstimateHistocompatibility TestingReoperationCohort StudiesKidneyBile Duct DiseasesHerpesvirus 6, HumanPortal VeinKidney Failure, ChronicCholangitis, SclerosingHepacivirusAzathioprineBiliary Tract DiseasesHeart-Lung TransplantationMultivariate AnalysisLiver Cirrhosis, AlcoholicHepatitis C, ChronicAlanine TransaminaseBK VirusDonor SelectionViremiaPatient SelectionBronchiolitis ObliteransHepatitis BKidney DiseasesProportional Hazards ModelsDrug MonitoringLiver RegenerationHerpesvirus 7, HumanMuromonab-CD3Pancreas TransplantationFatty LiverGlomerular Filtration RateKidney Function Tests